Bergstrom Donald A

President, R&D

Bergstrom Donald A has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.

On the most recent filing, Bergstrom Donald A is listed as President, R&D at Relay Therapeutics, Inc. Inside the rolling window, Bergstrom Donald A reported no open-market purchases and 8 open-market sales totaling $2.4M in RLAY. The largest disclosed transaction in the window is a sale of 93,456 RLAY shares on Jun 22, 2026, worth $1.6M.

Companies traded

Other insiders at RLAY

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RLAYSale$162KSep 9SEC ↗
RLAYSale$42KJul 30SEC ↗
RLAYSale$162KJul 8SEC ↗
RLAYSale$1.6MJun 24SEC ↗
RLAYSale$22KApr 30SEC ↗
RLAYSale$144KJan 29SEC ↗
RLAYSale$23KJan 29SEC ↗
RLAYSale$225KOct 30SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Bergstrom Donald A made?

Bergstrom Donald A has filed 7 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.

Which companies does Bergstrom Donald A trade?

Bergstrom Donald A has filed SEC Form 4 disclosures for 1 company, including RLAY.

When was Bergstrom Donald A's most recent SEC Form 4 filing?

Bergstrom Donald A's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.

What is Bergstrom Donald A's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Bergstrom Donald A is listed as President, R&D.

What is Bergstrom Donald A's total buy and sell value in the current window?

Inside the rolling retention window, Bergstrom Donald A bought $0 and sold $2.4M based on SEC Form 4 filings.

What was Bergstrom Donald A's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 93,456 RLAY shares on 2026-06-22, worth $1.6M, per SEC Form 4 filings.